[1]Hamashima,Toshihiko;Mori,Yoshiaki;Sawada,Kazunori;Kasahara,Yuko;Murayama,Daisuke;Kamei,Yuto;Okuno,Hiroaki;Yokoyama,Yuusaku;Suzuki,Hideharu[ChemicalandPharmaceuticalBulletin,2013,vol.61,#3,p.292-303]
1416440-37-3
141814-57-5 | (4-Methylmorpholin-2-yl)methanamine | AA001H66 | MFCD03990582
14206-69-0 | 3-Amino-5-hydroxybenzoic acid, HCl | AA001HM1 | MFCD00043420
142253-50-7 | (S)-tert-Butyl 2-(cyanomethyl)pyrrolidine-1-carboxylate | AA001HZN | MFCD03094801
19141-85-6 | 4-Ethyl-1H-imidazole | AA001IIB | MFCD20617036
144167-50-0 | Ethyl 5-bromo-1H-benzo[d]imidazole-2-carboxylate | AA001IYC | MFCD10566650
14446-24-3 | 1,2,3,4-Tetrahydroisoquinolin-6-ol | AA001JI2 | MFCD01717047
144650-93-1 | Sulfo-n-succinimidyl (n-iodoacetyl)aminobenzoate | AA001JUS | MFCD00054977
1449117-76-3 | tert-Butyl 4-(2-(4-(hydroxymethyl)-1h-pyrazol-1-yl)pyridin-4-yl)piperazine-1-carboxylate | AA001K9Q | MFCD23704674
145218-19-5 | 5-Bromo-2-(bromomethyl)pyridine | AA001KL9 | MFCD09999975
148440-81-7 | thioperamide maleate salt | AA001KUY | MFCD00083209
